About
Respiratory Treatments
Areas of Focus
Categories
Small Molecule Pharmaceutical
Team (28)
Amit Munshi
Chairman
Enterprise Therapeutics
board_chair
Annabella Amatulli
Head of Regulatory
Enterprise Therapeutics
team_member
Bart Dzikowski
Investor Director, NVF
Enterprise Therapeutics
team_member
Craig Richardson
Investor Director
Enterprise Therapeutics
team_member
Dr Alex Mayweg
Investor Director
Enterprise Therapeutics
team_member
Dr Eddie French
Head of CMC
Enterprise Therapeutics
team_member
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
3
As Collaborator
0
Total Enrollment
235
By Phase
PHASE2: 1PHASE1: 2
By Status
COMPLETED: 2ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT06478706Lead Sponsor
A Two-Part Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of Repeat Doses of Inhaled ETD001 in People With Cystic Fibrosis
PHASE2Active, not recruiting
57 participants
Started: Jun 26, 2024 · Completed: Nov 30, 2025
NCT04926701Lead Sponsor
A First in Human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of Inhaled ETD001 in Healthy Subjects
PHASE1Completed
98 participants
Started: Jun 11, 2021 · Completed: Mar 22, 2022
NCT04488705Lead Sponsor
A First in Human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of Inhaled ETD002 in Healthy Subjects
PHASE1Completed
80 participants
Started: Aug 13, 2020 · Completed: May 19, 2021
Locations (1)
Headquarters
Brighton, UK
Map
Loading map...